Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Jerome Levine, M.D.
JCP
Original Research
How Dosing of Ziprasidone in a State Hospital System Differs From Product Labeling
July 21, 2009
Leslie Citrome
,
Ari Jaffe
,
Jerome Levine
JCP
Original Research
Dosing of Quetiapine in Schizophrenia: How Clinical Practice Differs From Registration Studies
December 15, 2005
Leslie Citrome
,
Jean-Pierre Lindenmayer
,
Ari Jaffe
, et al
JCP
Article
Efficacy and Effectiveness of First- and Second-Generation Antipsychotics in Schizophrenia
November 1, 2003
Jerome Levine
,
Ari B. Jaffe
JCP
Original Research
A Naturalistic Study of Risperidone Treatment Outcome Using Prognosis-Adjusted Discharge Rates in New York State Inpatients
July 16, 2002
Jerome Levine
,
Daniel C. Javitt
,
Angel Cienfuegos
, et al
